Compare
Farxiga vs. Ozempic

Farxiga, the brand name for dapagliflozin, is used together with a nutritious diet and exercise plan to lower blood sugar levels in people 10 years and older with Type 2 diabetes. It can also help lower the risk of serious complications, hospitalization, and death in certain adults with heart failure or chronic kidney disease (CKD). Farxiga (dapagliflozin) belongs to the drug class called sodium-glucose cotransporter 2 (SGLT2) inhibitors. It's taken by mouth once a day. Some side effects include yeast infections, urinating more often, and weight loss.

• Type 2 diabetes (in addition to diet and exercise) in people age 10 and over
• Lowering the risk of hospitalization for heart failure in adults with Type 2 diabetes and heart disease
• Lowering the risk of hospitalization and death due to heart problems in people with heart failure
• Lowering the risk of worsening kidney problems, hospitalization for heart failure, and death due to heart problems in adults with chronic kidney disease (CKD)

• Vaginal yeast infection in females (7-8%)
• Nose and throat infection (6-7%)
• Urinary tract infection (UTI, 4-6%)

• Ketoacidosis
• Low fluids in the body (leading to low blood pressure or dehydration)
• Genital and urinary tract infections
• Low blood sugar (hypoglycemia) when used with other diabetes medications

Ozempic (semaglutide) is a GLP-1 agonist used with diet and exercise to help adults manage Type 2 diabetes. It can also lower the risk of heart attack, stroke, and heart-related death in some people with Type 2 diabetes. It comes as a once-weekly injection under the skin and as a tablet taken by mouth once a day. The injection is also approved to help slow worsening kidney problems in people with Type 2 diabetes and chronic kidney disease (CKD). Common side effects include nausea, vomiting, and diarrhea.

Injection:

• Type 2 diabetes
• Lower the risk of heart attack, stroke, and heart-related death in adults with Type 2 diabetes and heart disease
• Lower the risk of worsening kidney problems and heart-related death in adults with Type 2 diabetes and chronic kidney disease (CKD)

Tablets:

• Type 2 diabetes
• Lower the risk of heart attack, stroke, and heart-related death in adults with Type 2 diabetes at high risk for these events

• Nausea (16-20%)
• Diarrhea (9%)
• Vomiting (5-9%)
• Stomach pain (6-7%)
• Constipation (3-5%)

Note: Side effects listed above are for Ozempic (semaglutide) injection

• Risk of thyroid tumors
• Inflammation of the pancreas (pancreatitis)
• Eye problems
• Low blood sugar (hypoglycemia) when taken with certain diabetes medications
• Kidney damage
• Severe stomach problems
• Severe allergic reactions
• Gallbladder problems
• Lung problems during anesthesia or deep sedation